IEC 61000-4-11) and is subject to particular precautions with
regard to electromagnetic compatibility. Please note that
portable and mobile HF communication systems may inter-
fere with this device.
• The device complies with Regulation (EU) 2017/745 of the
European Parliament and of the Council for medical devices
as well as the respective national regulations and the stand-
ard IEC 80601-2-30 (Medical electrical equipment Part 2-30
– Particular requirements for basic safety and essential per-
formance of automated non-invasive sphygmomanometers).
• The accuracy of this blood pressure monitor has been care-
fully checked and developed with regard to a long useful life.
If the device is used for commercial medical purposes, the
applicable national regulations determine whether it must be
tested for accuracy by appropriate means.
Mains part
Model no.
LXCP12-006060BEH
Input
100 – 240 V, 50 – 60 Hz, 0.5 A max
Output
6 V DC, 600 mA, in conjunction with Beurer
blood pressure monitors only
Manufacturer
Shenzhen Iongxc power supply co., ltd.
Protection
This device is double protected and has a pri-
mary-side cutout switch which disconnects the
device from the mains in case of malfunction.
Ensure that you have removed the batteries
from the battery compartment before you use
the mains part.
Polarity of the DC voltage connection
Insulated/protection class 2
Housing and
The housing of the mains part protects users
protective
from touching live parts or parts that could be
covers
live (for example with their fingers, or with a
needle or checking hook).
The user must not touch the patient and the
output connector of the AC/DC mains part at
the same time.
12. GUARANTEE/SERVICE
Further information on the guarantee and guarantee conditions
can be found in the guarantee leaflet supplied.
Notification of incidents
For users/patients in the European Union and identical regula-
tion systems, the following applies: If during or through use of
the product a major incident occurs, notify the manufacturer and/
or their representative of this as well as the respective national
authority of the member state in which the user/patient is located.
33